Author: <span>Lynette Zilio</span>
Asbestos (general), asbestos exposure, Doctors/Specialists, Legal, mesothelioma, Mesothelioma News, Surgical procedures

$39M Awarded in Talc Pleurodesis Mesothelioma Case

 

A jury awarded $39 million to a family in a lawsuit related to the use of talc in a medical procedure. Plaintiff Bryce Zundel was diagnosed with mesothelioma in 2021 and underwent the procedure at the center of the case in 2014. Zundel’s lawsuit claimed the talc used in his pleurodesis was contaminated with asbestos. […]

The post $39M Awarded in Talc Pleurodesis Mesothelioma Case appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Asbestos (general), asbestos exposure, Doctors/Specialists, Legal, mesothelioma, Mesothelioma News, Surgical procedures

$39M Awarded in Talc Pleurodesis Mesothelioma Case

 

A jury awarded $39 million to a family in a lawsuit related to the use of talc in a medical procedure. Plaintiff Bryce Zundel was diagnosed with mesothelioma in 2021 and underwent the procedure at the center of the case in 2014. Zundel’s lawsuit claimed the talc used in his pleurodesis was contaminated with asbestos. […]

The post $39M Awarded in Talc Pleurodesis Mesothelioma Case appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Asbestos (general), asbestos exposure, Companies, johnson, lawsuit, Legal, mesothelioma, Mesothelioma News, Talcum powder

Judge Overturns $260M J&J Mesothelioma Talc Verdict

 

A new trial is being ordered in Oregon after a judge overturned a jury’s $260 million mesothelioma verdict against Johnson & Johnson. Judge Katharine von Ter Stegge of the Oregon 4th Judicial District Circuit Court granted J&J’s motion. Judge von Ter Stegge will soon release a written statement explaining her decision. Plaintiff Kyung Lee plans […]

The post Judge Overturns $260M J&J Mesothelioma Talc Verdict appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Chemotherapy/Chemo drugs, Clinical Trials/Research/Emerging Treatments, Immunotherapy, mesothelioma, Mesothelioma News, Treatment

FDA Approves Keytruda With Chemotherapy to Treat Mesothelioma

 

The U.S. Food and Drug Administration has approved a new first-line treatment for people with pleural mesothelioma that can’t be removed with surgery. This new approval is specifically for a Keytruda (pembrolizumab) plus pemetrexed and platinum chemotherapy combination.  The FDA’s approval follows promising results in phases 2 and 3 of the Keynote-483 trial. This clinical […]

The post FDA Approves Keytruda With Chemotherapy to Treat Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Cancer Center, Doctors/Specialists, Mesothelioma News, Treatment

Top Mesothelioma Hospitals Lead Best Cancer Hospitals List

 

U.S. News & World Report has named University of Texas MD Anderson Cancer Center the Best Hospital for Cancer for the tenth year in a row. Memorial Sloan Kettering Cancer Center in New York claimed the second spot on the list. Mayo Clinic in Rochester, Dana-Farber Brigham Cancer Center in Boston and City of Hope […]

The post Top Mesothelioma Hospitals Lead Best Cancer Hospitals List appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Asbestos (general), asbestos exposure, Companies, johnson, lawsuit, Legal, mesothelioma, Mesothelioma News

J&J Reaches $700 Million Talc Settlement

 

Johnson & Johnson will pay $700 million to settle an investigation concerning the marketing practices of its talc-based products. The multimillion-dollar settlement resolves charges that J&J misled people to believe its talc products, including Johnson’s Baby Powder and Johnson & Johnson’s Shower to Shower, were safe. The company is also facing more than 61,000 lawsuits […]

The post J&J Reaches $700 Million Talc Settlement appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

asbestos exposure, Companies, johnson, Legal, mesothelioma, Mesothelioma News, talc, Talcum powder, verdict

J&J Ordered to Pay $45M in Talc Baby Powder Lawsuit

 

An Illinois jury’s verdict orders defendants Johnson & Johnson and Kenvue to pay $45 million to the family of a woman who died of mesothelioma. The plaintiffs in the case were the family of Theresa Garcia whose lawsuit claimed J&J’s talc-based baby powder was tainted with asbestos.  The jury found Kenvue 70% responsible for Garcia’s […]

The post J&J Ordered to Pay $45M in Talc Baby Powder Lawsuit appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Clinical Trials/Research/Emerging Treatments, Mesothelioma News, Treatment

Mesothelioma Immunotherapy Receives Orphan Drug Designation

 

A novel therapy for mesothelioma has been given orphan drug designation by the U.S. Food and Drug Administration.  Avenge Bio, a biotechnology company working on a new treatment platform for immunotherapy, announced it was granted the designation for its drug  AVB-001 in June. It is currently enrolling patients in ongoing phase 1 and phase 2 […]

The post Mesothelioma Immunotherapy Receives Orphan Drug Designation appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Mesothelioma News

Latest Mesothelioma T-Cell Clinical Trial Moves to Phase II

 

The most recent T-cell therapy aimed at mesothelioma cancer has advanced to phase II of the clinical trial process, with researchers exploring its effectiveness when combined with an already approved immunotherapy duet. Investigators are studying the synergistic effect of gavocabtagene autoleucel (gavo-cel) when used with the combination of Opdivo and Yervoy, which was approved by […]

The post Latest Mesothelioma T-Cell Clinical Trial Moves to Phase II appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Mesothelioma News

$36.5 Million Verdict Could Change Asbestos Litigation in Libby, Montana

 

A Montana District Court jury recently delivered a $36.5 million verdict in a bellwether case that is expected to significantly change the landscape of future litigation involving vermiculite mining and asbestos exposure in Libby, Montana. The jury in Great Falls, Montana, awarded laborer Ralph Hutt $6.5 million in compensatory damages and $30 million in punitive […]

The post $36.5 Million Verdict Could Change Asbestos Litigation in Libby, Montana appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Mesothelioma News

Mayo Clinic Opens Novel Clinical Trial for Mesothelioma

 

Researchers at the much-acclaimed Mayo Clinic in Rochester, Minnesota, have opened the first clinical trial for mesothelioma patients that combines a recently approved immunotherapy treatment with targeted radiation. Potential for extending survival is there. This single-center phase I clinical trial opens June 24, and is expected to enroll at least 20 participants. It will study […]

The post Mayo Clinic Opens Novel Clinical Trial for Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.